Organoid models of drug resistant gastric adenosquamous carcinoma: Recapitulating tumor features and refining precision treatment

IF 15.8 1区 医学 Q1 PHARMACOLOGY & PHARMACY Drug Resistance Updates Pub Date : 2025-01-07 DOI:10.1016/j.drup.2025.101201
Kuan Li , Wenchao Li , Shuying Fu , Chen Wang , Kexin Wang , Huan Yang , Yumei Xian , Tengfei Hao , Shiwei Zhang , Tianshun Gao , Jie Zhou , Jia Li , Changhua Zhang , Wei Chen , Leli Zeng , Yulong He
{"title":"Organoid models of drug resistant gastric adenosquamous carcinoma: Recapitulating tumor features and refining precision treatment","authors":"Kuan Li ,&nbsp;Wenchao Li ,&nbsp;Shuying Fu ,&nbsp;Chen Wang ,&nbsp;Kexin Wang ,&nbsp;Huan Yang ,&nbsp;Yumei Xian ,&nbsp;Tengfei Hao ,&nbsp;Shiwei Zhang ,&nbsp;Tianshun Gao ,&nbsp;Jie Zhou ,&nbsp;Jia Li ,&nbsp;Changhua Zhang ,&nbsp;Wei Chen ,&nbsp;Leli Zeng ,&nbsp;Yulong He","doi":"10.1016/j.drup.2025.101201","DOIUrl":null,"url":null,"abstract":"<div><div>Organoids were successfully established from primary tumor and its metastatic lymph nodes of a patient. These organoids faithfully replicated tumor pathology and genetic characteristics. Organoid-based drug screening was conducted, which revealed significant difference in sensitivity to drugs between organoids dervived from primary tumor versus metastatic lymph nodes. The results guided clinical decisions for personalized treatment for the patient. This approach provides an insightful strategy for advancing treatment for gastric cancer.</div></div>","PeriodicalId":51022,"journal":{"name":"Drug Resistance Updates","volume":"79 ","pages":"Article 101201"},"PeriodicalIF":15.8000,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Resistance Updates","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1368764625000019","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Organoids were successfully established from primary tumor and its metastatic lymph nodes of a patient. These organoids faithfully replicated tumor pathology and genetic characteristics. Organoid-based drug screening was conducted, which revealed significant difference in sensitivity to drugs between organoids dervived from primary tumor versus metastatic lymph nodes. The results guided clinical decisions for personalized treatment for the patient. This approach provides an insightful strategy for advancing treatment for gastric cancer.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
耐药胃腺鳞癌的类器官模型:概括肿瘤特征并改进精准治疗。
我们成功地从患者的原发肿瘤及其转移淋巴结中建立了类器官。这些类器官忠实地复制了肿瘤的病理和遗传特征。我们进行了基于类器官的药物筛选,发现来自原发肿瘤的类器官与来自转移性淋巴结的类器官对药物的敏感性存在显著差异。结果指导临床决策的个性化治疗的病人。这种方法为推进胃癌的治疗提供了一种有见地的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Resistance Updates
Drug Resistance Updates 医学-药学
CiteScore
26.20
自引率
11.90%
发文量
32
审稿时长
29 days
期刊介绍: Drug Resistance Updates serves as a platform for publishing original research, commentary, and expert reviews on significant advancements in drug resistance related to infectious diseases and cancer. It encompasses diverse disciplines such as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology, and clinical medicine. The journal addresses both basic research and clinical aspects of drug resistance, providing insights into novel drugs and strategies to overcome resistance. Original research articles are welcomed, and review articles are authored by leaders in the field by invitation. Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective. *Expert reviews in clinical and basic drug resistance research in oncology and infectious disease *Describes emerging technologies and therapies, particularly those that overcome drug resistance *Emphasises common themes in microbial and cancer research
期刊最新文献
The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond Structural and functional analyses of STM14_5441-STM14_5442: A potential mechanism for persister formation against aminoglycosides Dynamic evolution of KPC-230-mediated resistance to ceftazidime-avibactam during the treatment of carbapenem-resistant Klebsiella pnenmoniae Global dissemination of Klebsiella pneumoniae in surface waters: Genomic insights into drug resistance, virulence, and clinical relevance Osmotic stress influences microtubule drug response via WNK1 kinase signaling
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1